Press Releases

Active Biotech: Notice of Annual General Meeting of Shareholders
April 26, 2016 12:03 (CEST)
Active Biotech plans to develop tasquinimod for the treatment of multiple myeloma
March 23, 2016 08:30 (CET)
Active Biotech AB Year-end report January - December 2015
February 18, 2016 08:34 (CET)
Active Biotech AB Year-end report January - December 2015
February 18, 2016 08:30 (CET)
Active Biotech: Information regarding the clinical study LEGATO-HD
January 11, 2016 08:37 (CET)
Active Biotech: Information regarding the clinical study LEGATO-HD
January 11, 2016 08:30 (CET)
Teva and Active Biotech Announce Discontinuation of Higher Doses of Laquinimod in Two Multiple Sclerosis Trials
January 4, 2016 15:00 (CET)
Active Biotech's election committee appointed
November 23, 2015 08:35 (CET)
Active Biotech's election committee appointed
November 23, 2015 08:30 (CET)
Active Biotech AB Interim report January - September 2015
November 6, 2015 08:32 (CET)